Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies.

about

Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies.

Item

http://www.wikidata.org/entity/Q48680314

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Comparative Study of Two Cohor ...... nge in Therapeutic Strategies.

@en

Comparative Study of Two Cohor ...... nge in Therapeutic Strategies.

@nl

type

Item

label

Comparative Study of Two Cohor ...... nge in Therapeutic Strategies.

@en

Comparative Study of Two Cohor ...... nge in Therapeutic Strategies.

@nl

prefLabel

Comparative Study of Two Cohor ...... nge in Therapeutic Strategies.

@en

Comparative Study of Two Cohor ...... nge in Therapeutic Strategies.

@nl

P1476

Comparative Study of Two Cohor ...... nge in Therapeutic Strategies.

@en

P2093

Amir Waizbard

http://www.w3.org/2001/XMLSchema#string

Ayala Yaron

http://www.w3.org/2001/XMLSchema#string

Guy Rosner

http://www.w3.org/2001/XMLSchema#string

Henit Yanai

http://www.w3.org/2001/XMLSchema#string

Iris Dotan

http://www.w3.org/2001/XMLSchema#string

Oded Icht

http://www.w3.org/2001/XMLSchema#string

Sigal Fishman

http://www.w3.org/2001/XMLSchema#string

Tomer Ziv-Baran

http://www.w3.org/2001/XMLSchema#string

Yulia Ron

http://www.w3.org/2001/XMLSchema#string

P2860

Infliximab maintenance therapy for fistulizing Crohn's disease

Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial.

Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.

European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease.

Efficacy of Adalimumab in Korean Patients with Crohn's Disease.

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

Efficacy of biological therapies in inflammatory bowel disease: systematic review and meta-analysis.

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.

P304

135-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000477438

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28848118

http://www.w3.org/2001/XMLSchema#string